7-Oxocholesteryl Acetate

7-Oxocholesteryl Acetate

SCHEMBL19858751

CC(=O)O[C@H]1CC[C@@]2(C)C(=CC(=O)[C@H]3[C@@H]4CC[C@H](C(C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 1/20 0.77
NPC1L1 Q9UHC9 7/20 0.74
RORA P35398 3/20 0.74
USP2 O75604 2/20 0.74
MEN1 O00255 1/20 0.74
ALOX15 P16050 1/20 0.74
KMT2A Q03164 1/20 0.74
CDC25A P30304 1/20 0.63
GABRA1 P14867 1/20 0.59
GABRB1 P18505 1/20 0.59
GABRG2 P18507 1/20 0.59
GABRB3 P28472 1/20 0.59
GABRA5 P31644 1/20 0.59
GABRA3 P34903 1/20 0.59
GABRA2 P47869 1/20 0.59
GABRA4 P48169 1/20 0.59
POLA1 P09884 1/20 0.55
CYP46A1 Q9Y6A2 2/20 0.54
RORC P51449 3/20 0.51
GPR183 P32249 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
7-Oxocholesteryl Acetate SCHEMBL27291551 1.00 NR1H3 (0.77) NR1H3NPC1L1RORAUSP2MEN1
7-Oxocholesteryl Acetate SCHEMBL4275934 1.00 NR1H3 (0.77) NR1H3NPC1L1RORAUSP2MEN1
7-Oxocholesteryl Acetate SCHEMBL14222168 1.00 NR1H3 (0.77) NR1H3NPC1L1RORAUSP2MEN1
7-Oxocholesteryl Acetate SCHEMBL14599124 1.00 NR1H3 (0.77) NR1H3NPC1L1RORAUSP2MEN1
7-Oxocholesteryl Acetate SCHEMBL4275938 1.00 NR1H3 (0.77) NR1H3NPC1L1RORAUSP2MEN1
7-Oxocholesteryl Acetate SCHEMBL24425752 1.00 NR1H3 (0.77) NR1H3NPC1L1RORAUSP2MEN1
7-Oxocholesteryl Acetate SCHEMBL19866270 1.00 NR1H3 (0.77) NR1H3NPC1L1RORAUSP2MEN1
7-Oxocholesteryl Acetate SCHEMBL19545214 1.00 NR1H3 (0.77) NR1H3NPC1L1RORAUSP2MEN1
7-Oxocholesteryl Acetate SCHEMBL21000253 1.00 NR1H3 (0.77) NR1H3NPC1L1RORAUSP2MEN1
7-Oxocholesteryl Acetate SCHEMBL7989640 1.00 NR1H3 (0.77) NR1H3NPC1L1RORAUSP2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112745253-B Preparation of vitamin D from stigmasterol 3 Is a new method for industrialization 成都健腾生物技术有限公司 2023-03-14 CN claimed
CN-110885354-B Preparation method of 7-ketone-cholesterol acetate 浙江新和成股份有限公司 2021-04-02 CN claimed
CN-110885354-A Preparation method of 7-ketone-cholesterol acetate 浙江新和成股份有限公司 2020-03-17 CN claimed
CN-107936077-A A kind of preparation method of 7 oxo cholesterol acetate 浙江天新药业有限公司 2018-04-20 CN claimed
US-20250319190-A1 APOE LIPOPROTEIN SYSTEMS KISBEE THERAPEUTICS INC (US) 2025-10-16 US disclosed
EP-4522646-A2 APOE LIPOPROTEIN SYSTEMS Kisbee Therapeutics, Inc. (US) 2025-03-19 EP disclosed
WO-2023220387-A2 APOE LIPOPROTEIN SYSTEMS KISBEE THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed
CN-112745253-B Preparation of vitamin D from stigmasterol 3 Is a new method for industrialization 成都健腾生物技术有限公司 2023-03-14 CN disclosed
CN-111925406-B Preparation method and application of 7-ketocholesterol acetate 上虞新和成生物化工有限公司 2021-08-17 CN disclosed
CN-113024625-A Preparation method of 7-ketone-cholesterol acetate 上海创诺医药集团有限公司 2021-06-25 CN disclosed
CN-113024625-A Preparation method of 7-ketone-cholesterol acetate 上海创诺医药集团有限公司 2021-06-25 CN disclosed
CN-110885354-B Preparation method of 7-ketone-cholesterol acetate 浙江新和成股份有限公司 2021-04-02 CN disclosed
CN-111925406-A Preparation method and application of 7-ketocholesterol acetate 上虞新和成生物化工有限公司 2020-11-13 CN disclosed
US-10729701-B2 Compounds that are analogs of squalamine, used as antibacterial agents VIRBAC (FR) 2020-08-04 US disclosed
CN-110885354-A Preparation method of 7-ketone-cholesterol acetate 浙江新和成股份有限公司 2020-03-17 CN disclosed
CN-107936077-A A kind of preparation method of 7 oxo cholesterol acetate 浙江天新药业有限公司 2018-04-20 CN disclosed
US-20180042942-A1 Compounds that are Analogs of Squalamine, Used as Antibacterial Agents VIRBAC (FR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250319190-A1 APOE LIPOPROTEIN SYSTEMS APOB, APOL1, LDLR NR1H3 16/4885NPC1L1 14/4885RORA 2643/4885
US-20180042942-A1 Compounds that are Analogs of Squalamine, Used as Antibacterial Agents SQLE, MTX1, SPIN1 NR1H3 3236/4885NPC1L1 1853/4885RORA 810/4885
US-10729701-B2 Compounds that are analogs of squalamine, used as antibacterial agents SQLE, MTX1, SPIN1 NR1H3 3236/4885NPC1L1 1853/4885RORA 810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.